Tejnaksh Healthcare Limited

About

Tejnaksh Healthcare Limited provides hospital and healthcare services in India. The company offers health care services through urology clinics, urology hospitals, and dental super specialty clinics; and operates multi-specialty hospitals, super-specialty hospitals, education institutes, pathology labs, super specialty training institutes, simulation institutes, and stone analysis labs. It also sells healthcare equipment, medical goods, and pharmaceuticals. In addition, the company is involved in the provision of inpatient and outpatient services. Tejnaksh Healthcare Limited was founded in 2003 and is headquartered in Dhule, India.

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	1.84	1.77	1.69	1.94	1.78	2.40	2.24	1.98	2.18	2.14	2.10	2.06	1.92
Expenses	1.14	0.96	1.09	1.23	1.04	1.23	0.89	1.05	1.15	1.04	1.04	1.10	1.40
Operating Profit	0.70	0.81	0.60	0.71	0.74	1.17	1.35	0.93	1.03	1.10	1.06	0.96	0.52
OPM %	38.04	45.76	35.50	36.60	41.57	48.75	60.27	46.97	47.25	51.40	50.48	46.60	27.08
Other Income	0.09	0.15	0.06	0.08	0.08	0.06	0.14	0.08	0.07	0.06	0.07	0.08	0.07
Depreciation	0.33	0.33	0.33	0.33	0.33	0.15	0.17	0.27	0.20	0.20	0.20	0.20	0.20
Interest	0.01	0.01	0.04	0.04	0.04	0.04	0.11	0.11	0.12	0.15	0.20	0.17	0.17
Profit before tax	0.45	0.62	0.29	0.42	0.45	1.04	1.21	0.63	0.78	0.81	0.73	0.67	0.22
Tax %	35.56	17.74	24.14	28.57	26.67	26.92	41.32	11.11	25.64	24.69	24.66	25.37	27.27
Net Profit	0.29	0.50	0.23	0.31	0.34	0.75	0.72	0.56	0.58	0.61	0.55	0.50	0.16
EPS in Rs	0.14	0.25	0.11	0.15	0.17	0.37	0.35	0.28	0.29	0.30	0.27	0.25	0.08

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	7.17	8.80	8.22	7.34	8.12	8.56	11.50	13.96	8.62	6.53	4.75	2.01
Expenses	4.32	4.31	4.57	4.21	3.76	4.96	7.93	10.34	4.37	3.67	2.45	1.04
Operating Profit	2.85	4.49	3.65	3.13	4.36	3.60	3.57	3.62	4.25	2.86	2.30	0.97
OPM %	39.75	51.02	44.40	42.64	53.69	42.06	31.04	25.93	49.30	43.80	48.42	48.26
Other Income	0.38	0.35	0.28	0.24	0.08	0.14	0.48	1.42	0.43	0.20	0.03	0.04
Interest	0.13	0.39	0.70	0.62	0.48	0.54	0.80	0.77	0.96	0.19	0.00	0.00
Depreciation	1.31	0.79	0.80	0.79	0.59	0.61	0.59	0.52	0.44	0.34	0.21	0.14
Profit before tax	1.79	3.66	2.43	1.96	3.37	2.59	2.66	3.75	3.28	2.53	2.12	0.87
Tax %	22.35	28.42	25.51	30.10	25.22	22.39	27.44	28.27	26.22	33.20	37.74	32.18
Net Profit	1.38	2.62	1.81	1.38	2.52	2.00	1.92	2.69	2.43	1.69	1.32	0.60
EPS in Rs	0.68	1.29	0.89	0.68	1.24	0.99	0.95	1.33	1.20	0.84	0.65	0.41
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	10.16	10.16	10.16	10.16	10.16	10.16	10.16	10.16	2.21	2.21	1.10	0.80
Reserves	16.64	15.25	12.62	10.79	9.40	6.87	4.85	2.93	8.19	5.73	5.14	1.69
Borrowings	0.25	1.05	4.79	6.45	7.03	4.93	7.25	6.33	7.64	6.39	0.00	0.00
Other Liabilities	2.17	2.55	2.55	2.40	2.09	1.92	2.02	1.99	1.13	0.55	0.60	1.04
Total Liabilities	29.22	29.01	30.12	29.80	28.68	23.88	24.28	21.41	19.17	14.88	6.84	3.53
Fixed Assets	21.01	20.14	22.14	22.51	14.55	14.34	16.59	16.19	14.54	13.43	3.34	2.86
CWIP	0.00	1.33	1.07	0.95	8.89	0.79	0.65	0.39	0.00	0.00	0.00	0.01
Investments	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	0.07	2.59	0.01
Other Assets	7.15	6.48	5.85	5.28	4.18	7.69	5.98	3.77	3.57	1.38	0.91	0.65
Total Assets	29.22	29.01	30.12	29.80	28.68	23.88	24.28	21.41	19.17	14.88	6.84	3.53

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	1.79	0.48	4.15	1.90	9.13	0.84	1.00	3.15	3.88	1.78	3.67	1.71
Cash from Investing Activity	-0.41	3.58	-1.08	-0.98	-10.40	1.56	-1.16	-1.49	-2.59	-7.91	-3.26	-1.59
Cash from Financing Activity	-1.20	-3.86	-2.31	-1.17	1.61	-2.86	0.22	-2.08	-0.64	6.39	-0.13	-0.04
Net Cash Flow	0.18	0.20	0.75	-0.25	0.35	-0.47	0.06	-0.42	0.64	0.26	0.29	0.08
Free Cash Flow	1.30	1.43	3.61	1.11	0.21	2.34	-0.25	1.65	3.04	-5.15	3.00	0.12
CFO/OP %	92.00	22.00	123.00	48.00	204.00	10.00	36.00	109.00	111.00	62.00	160.00	176.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	102.83	72.59	19.98	64.65	20.23	15.78	16.82	5.75	0.00	0.00	0.00	0.00
Inventory Days	309.46	207.77	236.18	142.64	251.90	340.67	182.50	—	126.74	86.45	98.06	—
Days Payable	87.28	84.23	75.15	117.47	77.11	129.78	143.79	—	177.43	134.47	114.40	—
Cash Conversion Cycle	325.01	196.12	181.01	89.82	195.02	226.67	55.53	5.75	-50.69	-48.03	-16.34	0.00
Working Capital Days	110.98	102.86	-6.66	53.71	-15.73	8.10	103.47	19.87	-63.94	19.56	-1.54	-5.45
ROCE %	7.18	14.99	11.39	9.56	16.07	14.20	16.60	24.13	26.20	26.45	48.57	36.29

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	73.83	73.83	73.83	73.83	73.83	73.83	73.83	73.83	73.83	73.83	73.83	73.83
FIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.58	0.58
Public	26.16	26.16	26.17	26.17	26.16	26.17	26.17	26.16	26.17	25.89	25.60	25.58
No. of Shareholders	4,395	4,414	4,452	4,550	4,552	4,493	4,496	4,067	3,776	3,502	3,057	2,628